Table 3 Comparison of in-hospital outcomes based on the presence or absence of metabolic syndrome
Metabolic Syndrome | ||||
|---|---|---|---|---|
Variables | All Patients (n = 190) | Absent (n = 103) | Present (n = 87) | P value |
In-hospital mortality | 15 (7.9%) | 4 (3.9%) | 11 (12.6%) | 0.026 |
Duration of ICU Stay>48 h | 67 (35.3%) | 32 (31.1%) | 35 (40.2%) | 0.188 |
Ventilation Time>48 h | 25 (13.2%) | 9 (8.7%) | 16 (18.4%) | 0.05 |
Reintubation | 12 (6.3%) | 4 (3.9%) | 8 (9.2%) | 0.134 |
Intra- and postoperative use of IABP | 16 (8.4%) | 4 (3.9%) | 12 (13.8%) | 0.014 |
Septicemia | 7 (3.7%) | 1 (1.0%) | 6 (6.9%) | 0.049 |
Ventricular fibrillation | 14 (7.4%) | 4 (3.9%) | 10 (11.5%) | 0.045 |
Acute renal failure | 21 (11.1%) | 6 (5.8%) | 15 (17.2%) | 0.012 |
Stroke | 4 (2.1%) | 1 (1.0%) | 3 (3.4%) | 0.334 |
LCOS | 12 (6.3%) | 4 (3.9%) | 8 (9.2%) | 0.134 |
Myocardial infarction | 8 (4.2%) | 2 (1.9%) | 6 (6.9%) | 0.145 |
New atrial fibrillation | 15 (7.9%) | 8 (7.8%) | 7 (8.0%) | 0.943 |
Gastrointestinal hemorrhage | 7 (3.7%) | 2 (1.9%) | 5 (5.7%) | 0.25 |